OHSU Rare Disease Research Consortium Symposium 2015: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
Line 10: Line 10:
:[http://www.ohsu.edu/xd/education/schools/school-of-medicine/departments/basic-science-departments/biochemistry-molecular-biology/ The OHSU Biochemistry and Molecular Biology Department]
:[http://www.ohsu.edu/xd/education/schools/school-of-medicine/departments/basic-science-departments/biochemistry-molecular-biology/ The OHSU Biochemistry and Molecular Biology Department]
:[http://www.ohsu.edu/xd/research/techtransfer/ OHSU Technology Transfer and Business Development]  
:[http://www.ohsu.edu/xd/research/techtransfer/ OHSU Technology Transfer and Business Development]  
:Additional support much appreciated from:
:[http://www.ohsu.edu/xd/research/centers-institutes/octri/ OCTRI, the Oregon Clinical and Translational Research Institute]
:[http://www.ohsu.edu/xd/research/centers-institutes/octri/ OCTRI, the Oregon Clinical and Translational Research Institute]
:OHSU Dean's Office, Communications.
:OHSU Dean's Office, Communications.

Revision as of 14:28, 3 April 2015

Equipped with his five senses, man explores the universe around him and calls the adventure Science. ~Edwin Powell Hubble, The Nature of Science, 1954


April 7, 2015, from 4-8:30 pm at OHSU in the Joseph Vey Conference Center

11th Floor, Doernbecher Children’s Hospital
700 SW Campus Drive
Portland, OR 97239

General Info

Register for the conference...it's free!

Registration has been reopened as of 11:30 am Friday. It will close again tonight at midnight.
Then only walk-in registrations will be accepted at the event.
It will be crowded--but terrific! Thank you all for your incredible interest in rare disease research.

Sponsors

A big Thank You for the support of this conference goes to
The OHSU School of Medicine for a Collaborative Grant
The OHSU Biochemistry and Molecular Biology Department
OHSU Technology Transfer and Business Development
OCTRI, the Oregon Clinical and Translational Research Institute
OHSU Dean's Office, Communications.

Schedule

Time Presenter Title
3:30 pm Registration opens (posters can be put up starting at 3pm)
4:00-5:00 Sekar Kathiresan, M.D.,Associate Professor of Medicine,

Harvard Medical School, Director of preventive cardiology at Massachusetts General Hospital

Leveraging human knockouts to understand risk for and protection from disease
5:00 to 6:10 Poster session and reception
6:10 to 6:20 Mary Stenzel-Poore, Ph.D.Senior Associate Dean for Research, OHSU School of Medicine Introduction to the conference
6:20 to 6:30 Laura Hays, Ph.D., Executive Director, Fanconi Anemia Research Fund Making a difference: the David Frohnmayer advocacy formula
6:30 to 6:35 Maureen Hoatlin, Ph.D.,MBA, Associate Professor Biochemistry and Molecular Biology, co-chair OHSU Rare Disease Research Consortium OHSU Rare Disease Consortium overview and objectives of the symposium
6:35 to 6:45 Eric Orwoll, M.D.., Professor of Medicine, Brittle Bone Disorder Rare Disease Research Clinical Network Osteogenesis imperfecta: a brittle bone disease with well-defined molecular pathologies but limited clinical insights and therapies
6:45 to 6:55 David Sprio, M.D., Chief Medical Officer and Co-founder, ReelDx, Associate Professor of Pediatrics, OHSU A novel real patient video platform that enables patients and clinicians to share rare disease phenotypes
6:55 to 7:05 Evan Shereck, M.D., Associate Professor of Pediatrics Overview of the program in Primary Immune Deficiency Treatment Consortium (PIDTC)
7:05 to 7:10 Markus Grompe, M.D., Fanconi anemia Program Project P.I., Professor, Departments of Pediatrics and Molecular and Medical Genetics, Director, Papé Family Pediatric Research Institute Program in Fanconi anemia
7:10 to 7:20 Cary Harding, M.D., Professor of Molecular and Medical Genetics and Pediatrics Clinical trials in inborn errrors of amino acid and fatty acid metabolism
7:20 to 7:40 David Ellison, M.D.,Professor of Medicine and Physiology & Pharmacology, Director of the Oregon Clinical and Translational Research Institute at OHSU
Part 1: All about that Bass: rare gene mutations and human blood pressure variation.
Part 2: How OCTRI can help rare disease research at OHSU
7:40 to 8:20 Xiaobing Quan, M.D., Ph.D, Executive Director, Translational Medicine at Regeneron Pharmaceuticals, Inc. Accelerating opportunities from discovery to clinic in rare disease research
8:20 to 8:25 Maureen Hoatlin, Ph.D, MBA Final remarks, organizing for the future
8:25 to 8:30 Trish Pruis, Ph.D. iPad Giveaway, random drawing of names of conference participants (must be present to win!)